Literature DB >> 6344604

The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.

J Mehta, P Mehta, C Horalek.   

Abstract

Alterations in platelet-generated thromboxane A2 (TXA2) and vessel wall-generated prostacyclin (PGI2) have been associated with myocardial ischemia. To examine TXA2-PGI2 equilibrium at rest and during exercise stress, we studied 13 normal subjects and 15 coronary artery disease patients. Plasma TXB2 and 6-keto-PGF1 alpha were measured as stable metabolites of TXA2 and PGI2, respectively, by radioimmunoassay. In normal subjects, plasma TXB2 levels increased 24% during exercise from 135 +/- 30 to 168 +/- 42 pg/ml (p = NS). Plasma 6-keto-PGF1 alpha levels increased 224% from 54 +/- 17 to 175 +/- 57 pg/ml (p less than 0.05). In coronary artery disease patients, although resting plasma TXB2 levels (mean 136 +/- 43 pg/ml) were comparable to levels in normal subjects, a greater increase (82%) occurred during exercise (mean 248 +/- 70 pg/ml; p less than 0.02 compared to resting levels). Resting plasma 6-keto-PGF1 alpha levels (mean 94 +/- 28 pg/ml) were also similar to normal subjects but increased only by 43% during exercise (mean 134 +/- 53 pg/ml; p = NS compared to resting levels). These data suggest that: in normal subjects TXA2 and PGI2 increase during exercise, PGI2 increasing more than TXA2, and although coronary disease patients have resting TXA2 and PGI2 levels in the normal range, TXA2 levels increase more than PGI2 levels during exercise. These observations may have a bearing on the mechanism of exercise-induced angina pectoris in certain coronary artery disease patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344604     DOI: 10.1016/0002-8703(83)90386-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjects.

Authors:  D L Feng; J Murillo; P Jadhav; C McKenna; O C Gebara; I Lipinska; J E Muller; G H Tofler
Journal:  Br J Sports Med       Date:  1999-12       Impact factor: 13.800

Review 2.  The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.

Authors:  J L Mehta; W W Nichols
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

3.  Physical activity and the triggering of myocardial infarction: the case for regular exercise.

Authors:  G H Tofler; M A Mittleman; J E Muller
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

4.  The effect of exercise on bleeding time and local production of prostacyclin and thromboxane.

Authors:  J W Carter; A E Ready; S Singhroy; E Duta; J M Gerrard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

5.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

6.  Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis.

Authors:  J L Mehta; D Lawson; P Mehta; T Saldeen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.

Authors:  James F Markworth; Luke Vella; Benjamin S Lingard; Dedreia L Tull; Thusitha W Rupasinghe; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-10-02       Impact factor: 3.619

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.